PATENT CLAIM ANALYSIS

Application Number: 15752635
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "265100"]

Abstract:
Janus kinase 1 selective inhibitors and pharmaceutical use thereof are provided.

Claim (Index 1):
A compound of Formula 1, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein, in Formula 1, R 1  is hydrogen, C 1-2  alkyl, or cyclopropylmethyl; R 2  is 2-cyanoacetyl, 2-cyanoethyl, butyl, 2-azidoacetyl, 3-methylbutanoyl, isobutoxycarbonyl, anilinocarbonyl, methylsulfonyl, (trifluoromethyl)sulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, (1-methyl-1H-imidazole-4-yl)sulfonyl, phenylsulfonyl, (2-fluorophenyl)sulfonyl, (3-fluorophenyl)sulfonyl, (4-fluorophenyl)sulfonyl, (2-cyanophenyl)sulfonyl, (3-cyanophenyl)sulfonyl, (4-cyanophenyl)sulfonyl, (2-nitrophenyl)sulfonyl, (3-nitrophenyl)sulfonyl, (4-nitrophenyl)sulfonyl, m-tolylsulfonyl, tosyl, (4-methoxyphenyl)sulfonyl, ((4-trifluoromethyl)phenyl)sulfonyl, naphthalene-2-ylsulfonyl, piperidine-1-ylsulfonyl, or morpholinosulfonyl.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15507409', '14183946', '13928696', '14715046', '13859569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7841844765696605
- 35 USC 102 Novelty (BERT): 0.5590213322685675
- Combined Prediction Score: 0.7616681621395512
- Mean Citation Score: 368.18293400000016
- Max Citation Score: 425.25983
- Similarity Product: 322.7432402414155

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test